UOC Laboratorio Centrale di Analisi, Istituto Giannina Gaslini, Genoa, Italy.
Pediatr Allergy Immunol. 2012 Aug;23(5):433-40. doi: 10.1111/j.1399-3038.2011.01228.x. Epub 2011 Nov 22.
It is well known that allergy evolves at clinical level from the birth to adulthood, and this has been clearly demonstrated also at a level of sensitization. However, little information is available on the evolution of the IgE repertoire directed to single allergenic components. In this cross-sectional, observational study, the evolution of the IgE repertoire was analysed at component level.
Serum samples from 901 allergic patients, stratified in 6 groups according to age, were analysed by ImmunoCAP ISAC, a microarray chip that allows to identify the presence of specific IgE towards 103 different allergen components. Total IgE were also evaluated.
The behaviour of total IgE according to age strictly paralleled that of the sum of specific IgE directed to molecular components. As expected, food-related components (in particular those of milk and egg) were the most frequently recognized in the earliest ages, whereas specific IgE to plant allergens appeared invariably later. Nonetheless, IgE specific to mite components was the most represented in all age classes. Of note, specific IgE against cross-reacting allergens was virtually absent in the first years and tended to appear only after the age of 6.
Despite this was not a study performed on a cohort of patients followed up from birth to adolescence, the molecular patterns of allergen recognition resulted modified according to age. These findings may support, at molecular level, the clinical features of the allergic march.
众所周知,过敏在临床水平上从出生到成年不断发展,这在致敏水平上也得到了明确的证明。然而,关于针对单一过敏原成分的 IgE 谱的演变,信息很少。在这项横断面观察研究中,我们分析了成分水平上 IgE 谱的演变。
我们分析了 901 名过敏患者的血清样本,这些患者根据年龄分为 6 组,采用 ImmunoCAP ISAC 进行分析,这是一种微阵列芯片,可识别针对 103 种不同过敏原成分的特异性 IgE。同时还评估了总 IgE。
总 IgE 随年龄的变化与针对分子成分的特异性 IgE 总和的变化严格平行。正如预期的那样,食物相关成分(特别是牛奶和鸡蛋的成分)在最早的年龄中最常被识别,而植物过敏原的特异性 IgE 则始终出现较晚。然而,螨类成分的特异性 IgE 是所有年龄组中最常见的。值得注意的是,交叉反应性过敏原的特异性 IgE 在最初几年几乎不存在,并且往往在 6 岁以后才出现。
尽管这不是一项对从出生到青春期进行随访的患者队列进行的研究,但过敏原识别的分子模式根据年龄发生了变化。这些发现可能在分子水平上支持过敏进程的临床特征。